Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia

Although KIT mutations are present in 20–25% of cases of t(8;21)(q22;q22) acute myeloid leukemia (AML), concurrent development of systemic mastocytosis (SM) is exceedingly rare. We examined the clinicopathologic features of SM associated with t(8;21)(q22;q22) AML in ten patients (six from our instit...

Descripción completa

Detalles Bibliográficos
Autores principales: Pullarkat, Sheeja T., Pullarkat, Vinod, Kroft, Steven H., Wilson, Carla S., Ahsanuddin, Arshad N., Mann, Karen P., Thein, Maung, Grody, Wayne W., Brynes, Russell K.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713498/
https://www.ncbi.nlm.nih.gov/pubmed/19669220
http://dx.doi.org/10.1007/s12308-009-0023-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713498/
https://www.ncbi.nlm.nih.gov/pubmed/19669220
http://dx.doi.org/10.1007/s12308-009-0023-2

Ejemplares similares